Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
ABOUT THIS PAGE
A LCZ 696 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of LCZ 696, including repackagers and relabelers. The FDA regulates LCZ 696 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. LCZ 696 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of LCZ 696 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A LCZ 696 supplier is an individual or a company that provides LCZ 696 active pharmaceutical ingredient (API) or LCZ 696 finished formulations upon request. The LCZ 696 suppliers may include LCZ 696 API manufacturers, exporters, distributors and traders.
click here to find a list of LCZ 696 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing LCZ 696 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for LCZ 696 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture LCZ 696 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain LCZ 696 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a LCZ 696 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of LCZ 696 suppliers with NDC on PharmaCompass.
LCZ 696 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of LCZ 696 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right LCZ 696 GMP manufacturer or LCZ 696 GMP API supplier for your needs.
A LCZ 696 CoA (Certificate of Analysis) is a formal document that attests to LCZ 696's compliance with LCZ 696 specifications and serves as a tool for batch-level quality control.
LCZ 696 CoA mostly includes findings from lab analyses of a specific batch. For each LCZ 696 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
LCZ 696 may be tested according to a variety of international standards, such as European Pharmacopoeia (LCZ 696 EP), LCZ 696 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (LCZ 696 USP).
LOOKING FOR A SUPPLIER?
